Anaplastic Oligodendroglioma (AO) Terminated Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01339039Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade GliomaTreatment